1. Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus. Issue 2 (28th January 2017) Authors: Furie, Richard; Khamashta, Munther; Merrill, Joan T.; Werth, Victoria P.; Kalunian, Kenneth; Brohawn, Philip; Illei, Gabor G.; Drappa, Jorn; Wang, Liangwei; Yoo, Stephen Journal: Arthritis & rheumatology Issue: Volume 69:Issue 2(2017) Page Start: 376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus. Issue 2 (February 2017) Authors: Furie, Richard; Khamashta, Munther; Merrill, Joan T.; Werth, Victoria P.; Kalunian, Kenneth; Brohawn, Philip; Illei, Gabor G.; Drappa, Jorn; Wang, Liangwei; Yoo, Stephen Journal: Arthritis & rheumatology Issue: Volume 69:Issue 2(2017) Page Start: 376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗